comparemela.com

Page 3 - Mark Alles News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A biotech startup with big-name backers aims to create new cancer medicines

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, as well.

vimarsana © 2020. All Rights Reserved.